Methotrexate Oral Solution
Methotrexate is an immunosuppressant.
Methotrexate Oral Solution is indicated for:
The maintenance treatment of Acute Lymphocytic Leukaemia (ALL) in children and adults.
The treatment of malignant trophoblastic tumours
The treatment of severe active rheumatoid arthritis in adults.
Polyarthritic forms of active, severe juvenile idiopathic arthritis (JIA) in adolescents and children aged 3 years and over when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequate.
The treatment of severe forms of psoriasis vulgaris including chronic plaque psoriasis, erythrodermic psoriasis, psoriatic arthritis and pustular psoriasis which are not responsive to other conventional therapies such as phototherapy, PUVA and retinoids.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Methotrexate Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Methotrexate Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Methotrexate Oral Solution
| Click here for Audio Version | |
| Flavour | Raspberry |
| Storage Conditions | Do not store above 25°C. Do not refrigerate. Store in original carton to protect from light. |
| Sucrose Free | |
| Shelf Life (Closed Bottle/Open Bottle) | 18 months / 3 months |
| PIP Code | 120-5053 |
| EAN Code | 05016119000416 |
| Sodium Levels | Essentially sodium-free |
| Ethanol Concentration | None |
Downloads
| Click here for Audio Version | |
| Flavour | Raspberry |
| Storage Conditions | Do not store above 25°C. Do not refrigerate. Store in original carton to protect from light. |
| Sucrose Free | |
| Shelf Life (Closed Bottle/Open Bottle) | 18 months / 3 months |
| PIP Code | 120-5046 |
| EAN Code | 05016119000423 |
| Sodium Levels | Essentially sodium-free |
| Ethanol Concentration | None |
Downloads
Adverse Drug Events
Information about adverse event reporting can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.
Related Products
